StockData
Prime Medicine, Inc. logo

Prime Medicine, Inc. (PRME) stock

PRMENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$3.84−0.35 (-8.35%)

Close on Nov 17, 2026Market cap $696.49MP/E –Yield –

Prime Medicine market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Prime Medicine's market cap was $777.17M on Nov 11, 2026, against $688.78M a year earlier. Over the last 5 years it ranged from $154.77M to $1.60B, with a median of $648.85M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$777.17M+24.2%
2025Dec 31, 2025$625.67M+63.4%
2024Dec 31, 2024$382.99M-55.6%
2023Dec 29, 2023$862.29M+38.3%
2022Dec 30, 2022$623.54M–

More Prime Medicine figures

See a number that looks wrong?